Published online Nov 27, 2023. doi: 10.4254/wjh.v15.i11.1250
Peer-review started: October 7, 2023
First decision: October 12, 2023
Revised: October 25, 2023
Accepted: November 13, 2023
Article in press: November 13, 2023
Published online: November 27, 2023
Processing time: 47 Days and 14.5 Hours
This letter to the editor relates to the study entitled "Non-invasive model for predicting high-risk esophageal varices based on liver and spleen stiffness". Acute bleeding caused by esophageal varices is a life-threatening complication in patients with liver cirrhosis. Due to the discomfort, contraindications, and associated complications of upper gastrointestinal endoscopy screening, it is crucial to identify an imaging-based non-invasive model for predicting high-risk esophageal varices in patients with cirrhosis.
Core Tip: Liver cirrhosis is the end of chronic liver disease. Rupture of esophageal varices (EVs) is a common and potentially fatal complication in patients with cirrhosis. In clinical practice, prophylactic treatment is primarily used to prevent events of esophageal venous bleeding, however, this strategy requires invasive and expensive upper gastrointestinal endoscopy testing, leading to poor patient adherence. In recent years, several studies have demonstrated an association between EVs and liver stiffness measurement (LSM) as well as spleen stiffness measurement (SSM). The main objectives of this paper are to elucidate the differences between EVs, SSM, and LSM and explore the feasibility of using LSM and SSM to develop a non-invasive model for predicting high-risk esophageal varices.
